Hisamitsu Pharmaceutical announced that it approved the share consolidation at an extraordinary general meeting of shareholders held on April 17, 2026, and will delist from the Tokyo, Nagoya, and Fukuoka Stock Exchanges on May 11, 2026. For details, please refer to the press release issued on the same date.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4530","jir_company_name":"Hisamitsu Pharmaceutical, Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2605","jir_publication_date":"2026-05-08","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/05\/4530-20260508-01.pdf","jir_short_summary":"Hisamitsu Pharmaceutical announced that it approved the share consolidation at an extraordinary general meeting of shareholders held on April 17, 2026, and will delist from the Tokyo, Nagoya, and Fukuoka Stock Exchanges on May 11, 2026. For details, please refer to the press release issued on the same date.","jir_summary":"### Overview of Business Performance\nThis document is an announcement regarding Hisamitsu Pharmaceutical's share consolidation and delisting. The proposal for share consolidation was approved at the extraordinary general meeting held on April 17, 2026, and consequently, the company will delist from the Tokyo Stock Exchange, Nagoya Stock Exchange, and Fukuoka Stock Exchange as of May 11, 2026. It does not include detailed financial figures or trends, nor does it contain information about future business outlook or financial condition.\n\n### Impact on Shareholders and Future Outlook\nDelisting may lead to changes in liquidity and trading environment for shares. The company expressed gratitude to long-term shareholders and stated its commitment to enhancing corporate value, but did not specify any particular business strategies or financial improvement measures. Investors should monitor the company's future developments and potential re-listing prospects.","jir_financial_highlights":"","jir_category":"","jir_hashtags":"#HisamitsuPharmaceutical, #IR, #JapanStocks","jir_key_figures":"Delisting date: 2026-05-11\nExtraordinary general meeting date: 2026-04-17\nTarget exchanges: Tokyo Stock Exchange, Nagoya Stock Exchange, Fukuoka Stock Exchange","jir_meta_title":"\u3010Hisamitsu Pharmaceutical\u3011 Share Consolidation and Delisting | May 2026","jir_meta_description":"Hisamitsu Pharmaceutical announced the approval of share consolidation in April 2026 and delisting scheduled for May 11. Stay tuned for more details and future outlooks.","jir_og_title":"\u3010Hisamitsu Pharmaceutical\u3011 Share Consolidation and Delisting | May 2026","jir_og_description":"Announcement regarding Hisamitsu Pharmaceutical's share consolidation and delisting. Investors should pay attention to future developments.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":8125,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-45940","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n